Nanobiotix (XPAR:NANO) Accounts Payable : €6.70 Mil (As of Dec. 2023)

View and export this data going back to 2012. Start your Free Trial

What is Nanobiotix Accounts Payable?

Nanobiotix's Accounts Payable for the quarter that ended in Dec. 2023 was €6.70 Mil.

Nanobiotix's quarterly Accounts Payable increased from Dec. 2022 (€4.00 Mil) to Jun. 2023 (€8.80 Mil) but then declined from Jun. 2023 (€8.80 Mil) to Dec. 2023 (€6.70 Mil).

Nanobiotix's annual Accounts Payable declined from Dec. 2021 (€5.00 Mil) to Dec. 2022 (€4.00 Mil) but then increased from Dec. 2022 (€4.00 Mil) to Dec. 2023 (€6.70 Mil).

Nanobiotix Accounts Payable Historical Data

The historical data trend for Nanobiotix's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanobiotix Accounts Payable Chart

Nanobiotix Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

Get a 7-Day Free Trial

6.15

5.57

5.00

4.00

6.70

Nanobiotix Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Payable	Get a 7-Day Free Trial															5.00	5.52	4.00	8.80	6.70

Nanobiotix Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Nanobiotix Accounts Payable Related Terms

Thank you for viewing the detailed overview of Nanobiotix's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Nanobiotix (XPAR:NANO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nanobiotix SA (XPAR:NANO) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

NBTX:USA 5NR:Germany

Address

60 Rue de Wattignies, Paris, FRA, 75012

Website

https://www.nanobiotix.com

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. It develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Nanobiotix (XPAR:NANO) Headlines

No Headlines